i-base

News

Featured HTB: issue 13 online: AIDS 2018 – first reports

PARTNER2, GEMINI, dolutegravir and pregnancy, DRV/r once-daily, cure research and more

Fit for Purpose: treatment optimisation reports

Fit for Purpose is an i-Base publication about HIV treatment strategies for low and middle-income countries. The latest edition was launched at the AIDS 2018 conference in Amsterdam in July 2018. Read July 2018 edition online. This report is currently …

Adult and paediatric optimised ART trial tracker

Trial Tracker is a new i-Base resource that will publish web-based tables that are routinely updated as research changes. While the formatting for the web pages is finalised, the summary tables are currently available as a Word document. Trial tracker …

AIDS 2018: early i-Base reports from Amsterdam

23 – 27 July 2018, Amsterdam Early reports i-Base reports, including from the HIV paediatric workshop held before AIDS 2018, will be added to the list of articles below. WHO recommends dolutegravir widely but women’s access will depend on contraception …

HTB: issue 12 online: DTG and preconception, AIDS 2018 and more (11 July 2018)

Contents online PDF of this issue Subscribe by email This HTB leads with a special report by Polly Clayden into the response to the recent safety alerts concerning dolutegravir (DTG) and its use preconception and a related article on balancing …

Featured HIV pipeline 2018: new drugs in development 

Simon Collins, HIV i-Base This is the second year that i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions will be available: 1. The full version reports key …

PrEP – a pocket guide (2018)

Pocket PrEP is an A7-sized guide to PrEP in the UK. It is an introduction to how PrEP works and buying PrEP online. Download pocket PrEP – PDF (400 Kb) Order free printed copies More pocket ART pages PrEP stands for pre-exposure prophylaxis. It is …

HTB: issue 11 online (29 June 2018): darunavir/cobicistat alert, PK reports and more

Contents online PDF of this issue Subscribe by email This issue of HTB starts with a treatment alert stating that cobicistat boosted darunavir is contraindicated in pregnant women. This is based on significantly reduced plasma levels of darunavir and cobicistat …

HTB: issue 10 online (08 June 2018): DTG alert, PK reports and more

Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…

HTB: issue 9 online (21 May 2018): DTG alert and BHIVA/BASHH reports

Contents online PDF of this issue Subscribe by email This issue of HTB leads with worrying reports of a potential signal of neural tube defects in four women taking dolutegravir at the time of conception. Importantly, there is no signal …

Featured U=U: Undetectable = Untransmittable

New Q&A on U=U… Has your doctor talked to you yet?

Questions about U=U: what, when, who, why….?

The following questions provide more information about why an undetectable viral load stops HIV transmission (U=U). What is U=U? U=U is an abbreviation for: Undetectable = Untransmittable It means that someone with an undetectable HIV viral load on HIV treatment …

HTB: issue 8 online (1 May 2018): special BHIVA/BASHH conference issue

4th BHIVA/BASHH conference in Edinburgh… access to services, new guidelines, standards of care, WeLoveKissing…

Featured Modern ART for Africa…

New resources with Treatment Action Campaign on modern ART in Africa…

HTB: issue 7 online (16 April 2018): (Another) special CROI issue

Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…

HTB: issue 6 online (30 March 2018): Special CROI issue

CROI reports: ibalizumab, pregnancy and review cure studies

HTB: issue 5 online (14 March 2018): Special CROI issue

CROI reports: bictegravir, PrEP and TB reports, plus cure-related research

Conference on Retroviruses and Opportunistic Infections (CROI 2018)

First reports: cure studies, new drugs for PrEP and HIV, breaking news for TB care…

HTB: issue 4 online (23 February 2018)

Looking ahead to CROI 2018, global use of dolutegravir, challenges of being transgender and positive…

HTB: issue 3 online (09 February 2018)

New drug approvals, HIV and pregnancy, guidelines and online resources…

Post navigation